{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:26:23Z","timestamp":1782311183254,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10875-021-01077-5","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T16:23:17Z","timestamp":1623342197000},"page":"1463-1478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico"],"prefix":"10.1007","volume":"41","author":[{"given":"Lina M.","family":"Castano-Jaramillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Yamazaki-Nakashimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"O\u2019Farrill-Romanillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Muzquiz Zerme\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma C.","family":"Scheffler Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Venegas Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Alberto","family":"Garc\u00eda Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz Mar\u00eda","family":"S\u00e1nchez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa B.","family":"G\u00e1mez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mois\u00e9s","family":"Ram\u00edrez L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Bustamante Ogando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"V\u00e1squez-Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Alejandro","family":"Medina Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Lopez-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth","family":"Blancas Galicia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Berr\u00f3n Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aid\u00e9 Tamara","family":"Staines-Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Elva","family":"Espinosa-Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Hilda","family":"Segura Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul O.","family":"Lugo Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"1077_CR1","unstructured":"Coronavirus Update (Live): 114,530,163 Cases and 2,539,955 Deaths from COVID-19 Virus Pandemic - Worldometer [Internet]. [cited 2021 Feb 28]. Available from: https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet Elsevier. 2020;395:1054\u201362.","journal-title":"The Lancet Elsevier"},{"key":"1077_CR3","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMcp2009249","volume":"383","author":"RT Gandhi","year":"2020","unstructured":"Gandhi RT, Lynch JB, Del Rio C. Mild or Moderate Covid-19. N Engl J Med. 2020;383:1757\u201366.","journal-title":"N Engl J Med"},{"key":"1077_CR4","doi-asserted-by":"crossref","unstructured":"Pietrobon AJ, Teixeira FME, Sato MN. I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People. Front Immunol. 2020;11:579220.","DOI":"10.3389\/fimmu.2020.579220"},{"key":"1077_CR5","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020;370."},{"key":"1077_CR6","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science [Internet]. American Association for the Advancement of Science; 2020 [cited 2021 Apr 21];370. Available from: https:\/\/science.sciencemag.org\/content\/370\/6515\/eabd4585"},{"key":"1077_CR7","first-page":"327","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34:327\u201331.","journal-title":"J Biol Regul Homeost Agents"},{"key":"1077_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369:718\u201324.","journal-title":"Science"},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24\u201364.","journal-title":"J Clin Immunol"},{"key":"1077_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2020.09.010","volume":"147","author":"I Meyts","year":"2021","unstructured":"Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, et al. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study. J Allergy Clin Immunol. 2021;147:520\u201331.","journal-title":"J Allergy Clin Immunol"},{"key":"1077_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.7326\/0003-4819-104-4-515","volume":"104","author":"HC Sox","year":"1986","unstructured":"Sox HC, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med. 1986;104:515\u201323.","journal-title":"Ann Intern Med"},{"key":"1077_CR12","unstructured":"Mayo Clinic Laboratories [Internet]. [cited 2021 Apr 21]. Available from: https:\/\/www.mayocliniclabs.com\/index.html"},{"key":"1077_CR13","doi-asserted-by":"crossref","unstructured":"Marcus N, Frizinsky S, Hagin D, Ovadia A, Hanna S, Farkash M, et al. Minor clinical impact of COVID-19 Pandemic on patients with primary immunodeficiency in Israel. Front Immunol. 2020;11:614086.","DOI":"10.3389\/fimmu.2020.614086"},{"key":"1077_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","volume":"146","author":"I Quinti","year":"2020","unstructured":"Quinti I, Lougaris V, Milito C, Cinetto F, Pecoraro A, Mezzaroma I, et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J Allergy Clin Immunol. 2020;146:211-213.e4.","journal-title":"J Allergy Clin Immunol"},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10875-020-00928-x","volume":"41","author":"S Delavari","year":"2021","unstructured":"Delavari S, Abolhassani H, Abolnezhadian F, Babaha F, Iranparast S, Ahanchian H, et al. Impact of SARS-CoV-2 pandemic on patients with primary immunodeficiency. J Clin Immunol. 2021;41:345\u201355.","journal-title":"J Clin Immunol"},{"key":"1077_CR16","doi-asserted-by":"crossref","unstructured":"Castano-Jaramillo LM, Yamazaki-Nakashimada MA, Scheffler Mendoza SC, Bustamante-Ogando JC, Espinosa-Padilla SE, Lugo Reyes SO. A male infant with COVID-19 in the context of ARPC1B deficiency. Pediatr Allergy Immunol. 2020;","DOI":"10.22541\/au.159170773.34049082"},{"key":"1077_CR17","doi-asserted-by":"crossref","unstructured":"Babaha F, Rezaei N. Primary immunodeficiency diseases in COVID-19 Pandemic: a predisposing or protective factor? Am J Med Sci [Internet]. 2020 [cited 2020 Oct 7]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7388814\/","DOI":"10.1016\/j.amjms.2020.07.027"},{"key":"1077_CR18","doi-asserted-by":"crossref","unstructured":"Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. Cold Spring Harbor Laboratory Press; 2020;2020.03.30.20047365.","DOI":"10.1101\/2020.03.30.20047365"},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.7150\/ijms.50537","volume":"17","author":"T Corse","year":"2020","unstructured":"Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han Z. Clinical outcomes of covid-19 patients with pre-existing, compromised immune systems: a review of case reports. Int J Med Sci. 2020;17:2974\u201386.","journal-title":"Int J Med Sci"},{"key":"1077_CR20","doi-asserted-by":"publisher","unstructured":"Icenogle T. COVID-19: Infection or Autoimmunity. Front Immunol [Internet]. Frontiers; 2020 [cited 2021 Feb 28];11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2020.02055\/full","DOI":"10.3389\/fimmu.2020.02055\/full"},{"key":"1077_CR21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.13495","volume":"202","author":"D Baker","year":"2020","unstructured":"Baker D, Roberts CAK, Pryce G, Kang AS, Marta M, Reyes S, et al. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases. Clin Exp Immunol. 2020;202:149\u201361.","journal-title":"Clin Exp Immunol"},{"key":"1077_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00296-020-04612-6","volume":"40","author":"ED Batu","year":"2020","unstructured":"Batu ED, \u00d6zen S. Implications of COVID-19 in pediatric rheumatology. Rheumatol Int. 2020;40:1193\u2013213.","journal-title":"Rheumatol Int"},{"key":"1077_CR23","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/S2352-3018(20)30163-6","volume":"7","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zhang C, Wang FS. COVID-19 in people with HIV. Lancet HIV. 2020;7:e524\u20136.","journal-title":"Lancet HIV"},{"key":"1077_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.24875\/AIDSRev.20000070","volume":"22","author":"AD Castel","year":"2020","unstructured":"Castel AD, Wilbourn B, Magnus M, Greenberg AE. SARS-CoV-2 and HIV: Epidemiology, Treatment, and Lessons Learned from HIV. AIDS Rev. 2020;22:133\u201342.","journal-title":"AIDS Rev"},{"key":"1077_CR25","doi-asserted-by":"crossref","unstructured":"Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol [Internet]. 2020 [cited 2021 Feb 28];11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7324760\/","DOI":"10.3389\/fimmu.2020.01518"},{"key":"1077_CR26","doi-asserted-by":"crossref","unstructured":"van den Berg DF, te Velde AA. Severe COVID-19: NLRP3 Inflammasome Dysregulated. Front Immunol [Internet]. 2020 [cited 2021 Feb 28];11. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7332883\/","DOI":"10.3389\/fimmu.2020.01580"},{"key":"1077_CR27","unstructured":"RT-PCR Testing [Internet]. [cited 2021 Feb 20]. Available from: https:\/\/www.idsociety.org\/covid-19-real-time-learning-network\/diagnostics\/RT-pcr-testing\/"},{"key":"1077_CR28","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(20)30275-7","volume":"2","author":"JJ Manson","year":"2020","unstructured":"Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T, et al. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. The Lancet Rheumatology Elsevier. 2020;2:e594-602.","journal-title":"The Lancet Rheumatology Elsevier"},{"key":"1077_CR29","doi-asserted-by":"crossref","unstructured":"Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;","DOI":"10.1001\/jama.2020.10369"},{"key":"1077_CR30","doi-asserted-by":"crossref","unstructured":"Belhadjer Z, M\u00e9ot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020;","DOI":"10.1161\/CIRCULATIONAHA.120.048360"},{"key":"1077_CR31","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607\u20138.","journal-title":"Lancet"},{"key":"1077_CR32","doi-asserted-by":"publisher","first-page":"253.e1","DOI":"10.1016\/j.ajem.2020.06.053","volume":"39","author":"S Sokolovsky","year":"2021","unstructured":"Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med. 2021;39:253.e1-253.e2.","journal-title":"Am J Emerg Med"},{"key":"1077_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.chest.2020.09.097","volume":"159","author":"MW Tenforde","year":"2021","unstructured":"Tenforde MW, Morris SB. Multisystem inflammatory syndrome in adults: coming into focus. CHEST Elsevier. 2021;159:471\u20132.","journal-title":"CHEST Elsevier"},{"key":"1077_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.chest.2020.08.2099","volume":"159","author":"G H\u00e9kimian","year":"2021","unstructured":"H\u00e9kimian G, Kerneis M, Zeitouni M, Cohen-Aubart F, Chommeloux J, Br\u00e9chot N, et al. Coronavirus Disease 2019 Acute myocarditis and multisystem inflammatory syndrome in adult intensive and cardiac care units. CHEST Elsevier. 2021;159:657\u201362.","journal-title":"CHEST Elsevier"},{"key":"1077_CR35","doi-asserted-by":"crossref","unstructured":"Rieber N, Hector A, Kuijpers T, Roos D, Hartl D. Current concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol. 2012;2012:252460.","DOI":"10.1155\/2012\/252460"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10875-011-9616-5","volume":"32","author":"A \u00c1lvarez-Cardona","year":"2012","unstructured":"\u00c1lvarez-Cardona A, Rodr\u00edguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease. J Clin Immunol. 2012;32:207\u201311.","journal-title":"J Clin Immunol"},{"key":"1077_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","volume":"40","author":"L Blancas-Galicia","year":"2020","unstructured":"Blancas-Galicia L, Santos-Ch\u00e1vez E, Deswarte C, Mignac Q, Medina-Vera I, Le\u00f3n-Lara X, et al. Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease. J Clin Immunol. 2020;40:475\u201393.","journal-title":"J Clin Immunol"},{"key":"1077_CR38","doi-asserted-by":"crossref","unstructured":"van der Vries E, Stittelaar KJ, van Amerongen G, Veldhuis Kroeze EJB, de Waal L, Fraaij PLA, et al. Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets. PLoS Pathog [Internet]. 2013 [cited 2020 Oct 7];9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3662664\/","DOI":"10.1371\/journal.ppat.1003343"},{"key":"1077_CR39","first-page":"91","volume":"24","author":"JAC Due\u00f1as","year":"2015","unstructured":"Due\u00f1as JAC. Prolonged viral shedding in an immunocompromised pediatric patient with influenza A H1N1 (2009): a case report and literature review. Alerg Asma Inmunol Pediatr Medigraphic. 2015;24:91\u20134.","journal-title":"Alerg Asma Inmunol Pediatr Medigraphic"},{"key":"1077_CR40","doi-asserted-by":"crossref","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D, et al. Covid-19 and autoimmunity. Autoimmunity Reviews. Elsevier; 2020;19:102597.","DOI":"10.1016\/j.autrev.2020.102597"},{"key":"1077_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s41927-020-00165-0","volume":"4","author":"J Ciaffi","year":"2020","unstructured":"Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatology. 2020;4:65.","journal-title":"BMC Rheumatology"},{"key":"1077_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33:155\u201362.","journal-title":"Curr Opin Rheumatol"},{"key":"1077_CR43","doi-asserted-by":"crossref","unstructured":"Soresina A, Moratto D, Chiarini M, Paolillo C, Baresi G, Foc\u00e0 E, et al. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr Allergy Immunol. 2020;","DOI":"10.1111\/pai.13263"},{"key":"1077_CR44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/jir.2020.0210","volume":"40","author":"BM Liu","year":"2020","unstructured":"Liu BM, Hill HR. Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review. J Interferon Cytokine Res. 2020;40:549\u201354.","journal-title":"J Interferon Cytokine Res"},{"key":"1077_CR45","doi-asserted-by":"crossref","unstructured":"Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, Luca GD, et al. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. The Lancet Rheumatology [Internet]. Elsevier; 2021 [cited 2021 Feb 28];0. Available from: https:\/\/www.thelancet.com\/journals\/lanrhe\/article\/PIIS2665-9913(21)00012-6\/abstract","DOI":"10.1016\/S2665-9913(21)00012-6"},{"key":"1077_CR46","doi-asserted-by":"crossref","unstructured":"REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N Engl J Med.\u00a02021;384:1491\u2013502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"1077_CR47","doi-asserted-by":"crossref","unstructured":"Rosas IO, Br\u00e4u N, Waters M, Go RC, Hunter BD, Bhagani S, et al. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med.\u00a02021;384:1503\u201316.","DOI":"10.1056\/NEJMoa2028700"},{"key":"1077_CR48","doi-asserted-by":"crossref","unstructured":"Pontali E, Volpi S, Signori A, Antonucci G, Castellaneta M, Buzzi D, et al. Efficacy of early anti-inflammatory treatment with high doses IV Anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. J Allergy Clin Immunol. 2021;147(4):1217\u201325.","DOI":"10.1016\/j.jaci.2021.01.024"},{"key":"1077_CR49","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. New England Journal of Medicine. Massachusetts Medical Society; 2021;384:693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"1077_CR50","doi-asserted-by":"crossref","unstructured":"Haji Abdolvahab M, Moradi-kalbolandi S, Zarei M, Bose D, Majidzadeh-A K, Farahmand L. Potential role of interferons in treating COVID-19 patients. Int Immunopharmacol. 2021;90:107171.","DOI":"10.1016\/j.intimp.2020.107171"},{"key":"1077_CR51","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12879-020-05425-5","volume":"20","author":"B Wang","year":"2020","unstructured":"Wang B, Li D, Liu T, Wang H, Luo F, Liu Y. Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study. BMC Infect Dis. 2020;20:723.","journal-title":"BMC Infect Dis"},{"key":"1077_CR52","doi-asserted-by":"publisher","unstructured":"Bastard P, L\u00e9vy R, Henriquez S, Bodemer C, Szwebel T-A, Casanova J-L. Interferon-\u03b2 therapy in a patient with incontinentia pigmenti and\u00a0autoantibodies against type I IFNs infected with SARS-CoV-2. J Clin Immunol. 2021:1\u20133. https:\/\/doi.org\/10.1007\/s10875-021-01023-5.","DOI":"10.1007\/s10875-021-01023-5"},{"key":"1077_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10875-020-00933-0","volume":"41","author":"R L\u00e9vy","year":"2021","unstructured":"L\u00e9vy R, Bastard P, Lanternier F, Lecuit M, Zhang S-Y, Casanova J-L. IFN-\u03b12a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2. J Clin Immunol. 2021;41:26\u20137.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-021-01077-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-021-01077-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T16:40:51Z","timestamp":1672418451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-021-01077-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s10875-021-01077-5","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved, as part of a larger project, by the Research and Ethics committees at the National Institute of Pediatrics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and to publish."}},{"value":"We have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}